Heterozygous UCHL1 loss-of-function variants cause a neurodegenerative disorder with spasticity, ataxia, neuropathy, and optic atrophy
Copyright © 2022 American College of Medical Genetics and Genomics. All rights reserved..
PURPOSE: Biallelic variants in UCHL1 have been associated with a progressive early-onset neurodegenerative disorder, autosomal recessive spastic paraplegia type 79. In this study, we investigated heterozygous UCHL1 variants on the basis of results from cohort-based burden analyses.
METHODS: Gene-burden analyses were performed on exome and genome data of independent cohorts of patients with hereditary ataxia and spastic paraplegia from Germany and the United Kingdom in a total of 3169 patients and 33,141 controls. Clinical data of affected individuals and additional independent families were collected and evaluated. Patients' fibroblasts were used to perform mass spectrometry-based proteomics.
RESULTS: UCHL1 was prioritized in both independent cohorts as a candidate gene for an autosomal dominant disorder. We identified a total of 34 cases from 18 unrelated families, carrying 13 heterozygous loss-of-function variants (15 families) and an inframe insertion (3 families). Affected individuals mainly presented with spasticity (24/31), ataxia (28/31), neuropathy (11/21), and optic atrophy (9/17). The mass spectrometry-based proteomics showed approximately 50% reduction of UCHL1 expression in patients' fibroblasts.
CONCLUSION: Our bioinformatic analysis, in-depth clinical and genetic workup, and functional studies established haploinsufficiency of UCHL1 as a novel disease mechanism in spastic ataxia.
Errataetall: |
ErratumIn: Genet Med. 2023 Oct;25(10):100961. - PMID 37650884 |
---|---|
Medienart: |
E-Artikel |
Erscheinungsjahr: |
2022 |
---|---|
Erschienen: |
2022 |
Enthalten in: |
Zur Gesamtaufnahme - volume:24 |
---|---|
Enthalten in: |
Genetics in medicine : official journal of the American College of Medical Genetics - 24(2022), 10 vom: 01. Okt., Seite 2079-2090 |
Sprache: |
Englisch |
---|
Beteiligte Personen: |
Park, Joohyun [VerfasserIn] |
---|
Links: |
---|
Themen: |
EC 3.4.19.12 |
---|
Anmerkungen: |
Date Completed 11.10.2022 Date Revised 31.08.2023 published: Print-Electronic ErratumIn: Genet Med. 2023 Oct;25(10):100961. - PMID 37650884 Citation Status MEDLINE |
---|
doi: |
10.1016/j.gim.2022.07.006 |
---|
funding: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
NLM345052765 |
---|
LEADER | 01000naa a22002652 4500 | ||
---|---|---|---|
001 | NLM345052765 | ||
003 | DE-627 | ||
005 | 20231226024207.0 | ||
007 | cr uuu---uuuuu | ||
008 | 231226s2022 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.1016/j.gim.2022.07.006 |2 doi | |
028 | 5 | 2 | |a pubmed24n1150.xml |
035 | |a (DE-627)NLM345052765 | ||
035 | |a (NLM)35986737 | ||
035 | |a (PII)S1098-3600(22)00843-7 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
100 | 1 | |a Park, Joohyun |e verfasserin |4 aut | |
245 | 1 | 0 | |a Heterozygous UCHL1 loss-of-function variants cause a neurodegenerative disorder with spasticity, ataxia, neuropathy, and optic atrophy |
264 | 1 | |c 2022 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a ƒaComputermedien |b c |2 rdamedia | ||
338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
500 | |a Date Completed 11.10.2022 | ||
500 | |a Date Revised 31.08.2023 | ||
500 | |a published: Print-Electronic | ||
500 | |a ErratumIn: Genet Med. 2023 Oct;25(10):100961. - PMID 37650884 | ||
500 | |a Citation Status MEDLINE | ||
520 | |a Copyright © 2022 American College of Medical Genetics and Genomics. All rights reserved. | ||
520 | |a PURPOSE: Biallelic variants in UCHL1 have been associated with a progressive early-onset neurodegenerative disorder, autosomal recessive spastic paraplegia type 79. In this study, we investigated heterozygous UCHL1 variants on the basis of results from cohort-based burden analyses | ||
520 | |a METHODS: Gene-burden analyses were performed on exome and genome data of independent cohorts of patients with hereditary ataxia and spastic paraplegia from Germany and the United Kingdom in a total of 3169 patients and 33,141 controls. Clinical data of affected individuals and additional independent families were collected and evaluated. Patients' fibroblasts were used to perform mass spectrometry-based proteomics | ||
520 | |a RESULTS: UCHL1 was prioritized in both independent cohorts as a candidate gene for an autosomal dominant disorder. We identified a total of 34 cases from 18 unrelated families, carrying 13 heterozygous loss-of-function variants (15 families) and an inframe insertion (3 families). Affected individuals mainly presented with spasticity (24/31), ataxia (28/31), neuropathy (11/21), and optic atrophy (9/17). The mass spectrometry-based proteomics showed approximately 50% reduction of UCHL1 expression in patients' fibroblasts | ||
520 | |a CONCLUSION: Our bioinformatic analysis, in-depth clinical and genetic workup, and functional studies established haploinsufficiency of UCHL1 as a novel disease mechanism in spastic ataxia | ||
650 | 4 | |a Journal Article | |
650 | 4 | |a Research Support, Non-U.S. Gov't | |
650 | 4 | |a Gene burden | |
650 | 4 | |a Proteomics | |
650 | 4 | |a Spastic ataxia | |
650 | 4 | |a UCHL1 | |
650 | 7 | |a UCHL1 protein, human |2 NLM | |
650 | 7 | |a Ubiquitin Thiolesterase |2 NLM | |
650 | 7 | |a EC 3.4.19.12 |2 NLM | |
700 | 1 | |a Tucci, Arianna |e verfasserin |4 aut | |
700 | 1 | |a Cipriani, Valentina |e verfasserin |4 aut | |
700 | 1 | |a Demidov, German |e verfasserin |4 aut | |
700 | 1 | |a Rocca, Clarissa |e verfasserin |4 aut | |
700 | 1 | |a Senderek, Jan |e verfasserin |4 aut | |
700 | 1 | |a Butryn, Michaela |e verfasserin |4 aut | |
700 | 1 | |a Velic, Ana |e verfasserin |4 aut | |
700 | 1 | |a Lam, Tanya |e verfasserin |4 aut | |
700 | 1 | |a Galanaki, Evangelia |e verfasserin |4 aut | |
700 | 1 | |a Cali, Elisa |e verfasserin |4 aut | |
700 | 1 | |a Vestito, Letizia |e verfasserin |4 aut | |
700 | 1 | |a Maroofian, Reza |e verfasserin |4 aut | |
700 | 1 | |a Deininger, Natalie |e verfasserin |4 aut | |
700 | 1 | |a Rautenberg, Maren |e verfasserin |4 aut | |
700 | 1 | |a Admard, Jakob |e verfasserin |4 aut | |
700 | 1 | |a Hahn, Gesa-Astrid |e verfasserin |4 aut | |
700 | 1 | |a Bartels, Claudius |e verfasserin |4 aut | |
700 | 1 | |a van Os, Nienke J H |e verfasserin |4 aut | |
700 | 1 | |a Horvath, Rita |e verfasserin |4 aut | |
700 | 1 | |a Chinnery, Patrick F |e verfasserin |4 aut | |
700 | 1 | |a Tiet, May Yung |e verfasserin |4 aut | |
700 | 1 | |a Hewamadduma, Channa |e verfasserin |4 aut | |
700 | 1 | |a Hadjivassiliou, Marios |e verfasserin |4 aut | |
700 | 1 | |a Tofaris, George K |e verfasserin |4 aut | |
700 | 0 | |a Genomics England Research Consortium |e verfasserin |4 aut | |
700 | 1 | |a Wood, Nicholas W |e verfasserin |4 aut | |
700 | 1 | |a Hayer, Stefanie N |e verfasserin |4 aut | |
700 | 1 | |a Bender, Friedemann |e verfasserin |4 aut | |
700 | 1 | |a Menden, Benita |e verfasserin |4 aut | |
700 | 1 | |a Cordts, Isabell |e verfasserin |4 aut | |
700 | 1 | |a Klein, Katrin |e verfasserin |4 aut | |
700 | 1 | |a Nguyen, Huu Phuc |e verfasserin |4 aut | |
700 | 1 | |a Krauss, Joachim K |e verfasserin |4 aut | |
700 | 1 | |a Blahak, Christian |e verfasserin |4 aut | |
700 | 1 | |a Strom, Tim M |e verfasserin |4 aut | |
700 | 1 | |a Sturm, Marc |e verfasserin |4 aut | |
700 | 1 | |a van de Warrenburg, Bart |e verfasserin |4 aut | |
700 | 1 | |a Lerche, Holger |e verfasserin |4 aut | |
700 | 1 | |a Maček, Boris |e verfasserin |4 aut | |
700 | 1 | |a Synofzik, Matthis |e verfasserin |4 aut | |
700 | 1 | |a Ossowski, Stephan |e verfasserin |4 aut | |
700 | 1 | |a Timmann, Dagmar |e verfasserin |4 aut | |
700 | 1 | |a Wolf, Marc E |e verfasserin |4 aut | |
700 | 1 | |a Smedley, Damian |e verfasserin |4 aut | |
700 | 1 | |a Riess, Olaf |e verfasserin |4 aut | |
700 | 1 | |a Schöls, Ludger |e verfasserin |4 aut | |
700 | 1 | |a Houlden, Henry |e verfasserin |4 aut | |
700 | 1 | |a Haack, Tobias B |e verfasserin |4 aut | |
700 | 1 | |a Hengel, Holger |e verfasserin |4 aut | |
700 | 1 | |a Ambrose, J C |e investigator |4 oth | |
700 | 1 | |a Arumugam, P |e investigator |4 oth | |
700 | 1 | |a Baple, E L |e investigator |4 oth | |
700 | 1 | |a Bleda, M |e investigator |4 oth | |
700 | 1 | |a Boardman-Pretty, F |e investigator |4 oth | |
700 | 1 | |a Boissiere, J M |e investigator |4 oth | |
700 | 1 | |a Boustred, C R |e investigator |4 oth | |
700 | 1 | |a Brittain, H |e investigator |4 oth | |
700 | 1 | |a Caulfield, M J |e investigator |4 oth | |
700 | 1 | |a Chan, G C |e investigator |4 oth | |
700 | 1 | |a Craig, C E H |e investigator |4 oth | |
700 | 1 | |a Daugherty, L C |e investigator |4 oth | |
700 | 1 | |a de Burca, A |e investigator |4 oth | |
700 | 1 | |a Devereau, A |e investigator |4 oth | |
700 | 1 | |a Elgar, G |e investigator |4 oth | |
700 | 1 | |a Foulger, R E |e investigator |4 oth | |
700 | 1 | |a Fowler, T |e investigator |4 oth | |
700 | 1 | |a Furió-Tarí, P |e investigator |4 oth | |
700 | 1 | |a Hackett, J M |e investigator |4 oth | |
700 | 1 | |a Halai, D |e investigator |4 oth | |
700 | 1 | |a Hamblin, A |e investigator |4 oth | |
700 | 1 | |a Henderson, S |e investigator |4 oth | |
700 | 1 | |a Holman, J E |e investigator |4 oth | |
700 | 1 | |a Hubbard, T J P |e investigator |4 oth | |
700 | 1 | |a Ibáñez, K |e investigator |4 oth | |
700 | 1 | |a Jackson, R |e investigator |4 oth | |
700 | 1 | |a Jones, L J |e investigator |4 oth | |
700 | 1 | |a Kasperaviciute, D |e investigator |4 oth | |
700 | 1 | |a Kayikci, M |e investigator |4 oth | |
700 | 1 | |a Lahnstein, L |e investigator |4 oth | |
700 | 1 | |a Lawson, K |e investigator |4 oth | |
700 | 1 | |a Leigh, S E A |e investigator |4 oth | |
700 | 1 | |a Leong, I U S |e investigator |4 oth | |
700 | 1 | |a Lopez, F J |e investigator |4 oth | |
700 | 1 | |a Maleady-Crowe, F |e investigator |4 oth | |
700 | 1 | |a Mason, J |e investigator |4 oth | |
700 | 1 | |a McDonagh, E M |e investigator |4 oth | |
700 | 1 | |a Moutsianas, L |e investigator |4 oth | |
700 | 1 | |a Mueller, M |e investigator |4 oth | |
700 | 1 | |a Murugaesu, N |e investigator |4 oth | |
700 | 1 | |a Need, A C |e investigator |4 oth | |
700 | 1 | |a Odhams, C A |e investigator |4 oth | |
700 | 1 | |a Patch, C |e investigator |4 oth | |
700 | 1 | |a Perez-Gil, D |e investigator |4 oth | |
700 | 1 | |a Polychronopoulos, D |e investigator |4 oth | |
700 | 1 | |a Pullinger, J |e investigator |4 oth | |
700 | 1 | |a Rahim, T |e investigator |4 oth | |
700 | 1 | |a Rendon, A |e investigator |4 oth | |
700 | 1 | |a Riesgo-Ferreiro, P |e investigator |4 oth | |
700 | 1 | |a Rogers, T |e investigator |4 oth | |
700 | 1 | |a Ryten, M |e investigator |4 oth | |
700 | 1 | |a Savage, K |e investigator |4 oth | |
700 | 1 | |a Sawant, K |e investigator |4 oth | |
700 | 1 | |a Scott, R H |e investigator |4 oth | |
700 | 1 | |a Siddiq, A |e investigator |4 oth | |
700 | 1 | |a Sieghart, A |e investigator |4 oth | |
700 | 1 | |a Smedley, D |e investigator |4 oth | |
700 | 1 | |a Smith, K R |e investigator |4 oth | |
700 | 1 | |a Sosinsky, A |e investigator |4 oth | |
700 | 1 | |a Spooner, W |e investigator |4 oth | |
700 | 1 | |a Stevens, H E |e investigator |4 oth | |
700 | 1 | |a Stuckey, A |e investigator |4 oth | |
700 | 1 | |a Sultana, R |e investigator |4 oth | |
700 | 1 | |a Thomas, E R A |e investigator |4 oth | |
700 | 1 | |a Thompson, S R |e investigator |4 oth | |
700 | 1 | |a Tregidgo, C |e investigator |4 oth | |
700 | 1 | |a Tucci, A |e investigator |4 oth | |
700 | 1 | |a Walsh, E |e investigator |4 oth | |
700 | 1 | |a Watters, S A |e investigator |4 oth | |
700 | 1 | |a Welland, M J |e investigator |4 oth | |
700 | 1 | |a Williams, E |e investigator |4 oth | |
700 | 1 | |a Witkowska, K |e investigator |4 oth | |
700 | 1 | |a Wood, S M |e investigator |4 oth | |
700 | 1 | |a Zarowiecki, M |e investigator |4 oth | |
773 | 0 | 8 | |i Enthalten in |t Genetics in medicine : official journal of the American College of Medical Genetics |d 1997 |g 24(2022), 10 vom: 01. Okt., Seite 2079-2090 |w (DE-627)NLM097536970 |x 1530-0366 |7 nnns |
773 | 1 | 8 | |g volume:24 |g year:2022 |g number:10 |g day:01 |g month:10 |g pages:2079-2090 |
856 | 4 | 0 | |u http://dx.doi.org/10.1016/j.gim.2022.07.006 |3 Volltext |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_NLM | ||
951 | |a AR | ||
952 | |d 24 |j 2022 |e 10 |b 01 |c 10 |h 2079-2090 |